IP Verse

Beta-1,3'-Galactosyllactose For The Treatment Of Gut Barrier Function Diseases

Patent No. EP3969009 (titled "Beta-1,3'-Galactosyllactose For The Treatment Of Gut Barrier Function Diseases") was filed by Nutricia on May 15, 2020. The application was issued on Aug 20, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
NESTLEMay 19, 2026D YOUNG
FRIESLANDCAMPINA NEDERLANDMay 6, 2026FRIESLANDCAMPINA DEPARTMENT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3969009

NUTRICIA
Application Number
EP20724883A
Filing Date
May 15, 2020
Status
Granted And Under Opposition
Jul 18, 2025
Publication Date
Aug 20, 2025
External Links
Slate, Register , Google Patents